ArticleLeukemia2018

Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy.

V K Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.